SMARCA4 and Parkinson disease: Furthermore, we revealed a potential common aging‐related pathogenic signaling pathway consisting of the chromatin‐remodeling factor SMARCA4 and the ERK‐ETS signaling axis, suggesting new therapeutic targets for PD and other aging‐related disorders, as three ERK‐ETS inhibitors were tested for their efficacy in multiple Drosophila PD models.